METHOD FOR DETERMINING GASTROINTESTINAL DYSBIOSIS Russian patent published in 2020 - IPC A61B5/00 

Abstract RU 2723336 C2

FIELD: medicine.

SUBSTANCE: disclosed is a method for determining the probability of dysbiosis of the gastrointestinal (GI) tract in a subject, a method for quantitative determination of dysbiosis, a method for obtaining information significant for diagnosis, monitoring and/or characterization of diseases and conditions associated with gastrointestinal microbiota disorders, diagnostic, monitoring and/or characteristics of diseases and conditions, associated with microbiota disorders of the GI tract, as well as a system for determining the probability of dysbiosis of the GI tract in a subject. Providing a set of experimental data containing at least one microbiota profile. Said microbiota profile is a profile of relative levels of a plurality of microorganisms or groups of microorganisms in a sample from the said individual's gastrointestinal tract. Application of said set of experimental data of at least one load vector, which is at least one orthogonal latent variable, determined by regression analysis of the levels of said plurality of microorganisms or groups of microorganisms in corresponding samples from the LC tract of a plurality of normal subjects. This provides a first set of projection data. Providing said first plurality of projection data. Calculating the Q-residue of the microbiota profile from said first plurality of projection data. Comparison of said Q-residue of microbiota profile with threshold value of Q-residue at transition from normobiotic to dysbiotic state, determined in corresponding analysis of said plurality of microorganisms or groups of microorganisms in corresponding samples from the GI tract of multiple normal subjects and/or subjects suffering from dysbiosis. Hotelling's T2 calculation from said first plurality of projection data for microbiota profile from dispersion, explained by said orthogonal hidden variables determined by regression analysis of levels of said plurality of microorganisms or groups of microorganisms in corresponding samples from the LC tract of a plurality of normal subjects. Comparison Hotelling's T2 for the microbiota profile with the Hotelling's T2 threshold value at transition from the normobiotic to the dysbiotic state, determined in corresponding analysis of said plurality of microorganisms or groups of microorganisms in corresponding samples from the LC tract of a plurality of normal subjects and/or a plurality of subjects suffering from dysbiosis. Moreover profile microbiota, Q-residue or Hotelling's T2 which is greater than said respective threshold values indicating the probability of dysbiosis.

EFFECT: group of inventions makes it possible to accurately and effectively determine the probability of gastrointestinal dysbacteriosis and to quantify its degree.

24 cl, 5 dwg, 12 tbl

Similar patents RU2723336C2

Title Year Author Number
AUXILIARY DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME USING CORRECTIVE DIET OR FECAL MICROBIOTA TRANSPLANTATION 2017
  • Khegge, Finn Tere
  • Kasen, Kristina
  • Valer, Jergen
  • Reset, Arne
  • Smostuen, Milada Chvancharova
RU2762266C1
THERAPEUTIC USE OF Lactobacillus plantarum 2018
  • Robertson, Anna-Karin
RU2772025C2
COMPOSITIONS AND METHODS 2014
  • Mckenzie Gregory
  • Mckenzie Mary-Jane Lombardo
  • Cook David
  • Vulic Marin
  • Von Maltzahn Geoffrey
  • Goodman Brian
  • Aunins John G.
  • Henn Matthew R.
  • Berry David A.
  • Winkler Jonathan
RU2664479C2
COMPOSITION AND METHOD OF TREATING AND PREVENTING INTESTINAL INFECTION AND INFLAMMATION 2016
  • Aghaibeik-Lavasani Shahram
  • Nouri Mehrnaz
RU2738803C2
SETS OF OLIGONUCLEOTIDE PROBES AND METHODS OF GASTROINTESTINAL MICROBIOTA PROFILING 2011
  • Vebe Khejdi
  • Rudi Knut
  • Sekelja Monika
RU2605913C2
COMPOSITIONS AND METHODS OF THE TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE 2019
  • Nandakumar, Madkhumitkha
  • O'Brajen, Edvard Dzh.
  • Datta, Sumon
RU2799556C2
USING LACTOBACILLUS REUTERI FOR RECOVERING MICROBIOTA AFTER DYSBIOSIS AT EARLY STAGES OF DEVELOPMENT 2015
  • Neville, Tara
  • Lepage, Melissa
  • Ngom-Bru, Catherine
  • Berger, Bernard
  • Garcia-Rodenas, Clara Lucia
RU2723687C2
WAY OF DIAGNOSTICS OF MICROBIOTA DISBALANCE OF VARIOUS HUMAN BIOTOPES AND DEGREE OF ITS EXPRESSION 2008
  • Lipova Elena Valerievna
  • Batkaev Ehdgem Abdulakhatovich
  • Vitvitskaja Julija Gennad'Evna
  • Trofimov Dmitrij Jur'Evich
  • Borodin Aleksandr Mikhajlovich
  • Boldyreva Margarita Nikolaevna
  • Skorkina Julija Aleksandrovna
  • Babaev Orkhan Rauf Ogly
RU2362808C1
DETECTION SYSTEM OF MOST SIGNIFICANT PROKARYOTIC REPRESENTATIVES OF HUMAN INTESTINAL MICROBIOTA BASED ON PCR PANEL 2017
  • Popenko Anna Sergeevna
  • Tyakht Aleksandr Viktorovich
  • Alekseev Dmitriy Glebovich
  • Klimenko Natalya Sergeevna
  • Filipenko Maksim Leonidovich
  • Shadrina Aleksandra Sergeevna
RU2680268C1
METHOD OF DIGESTIVE TRACT MICROBIOTA CONDITION EVALUATING IN ADOLESCENTS OF 14-18 YEARS OLD BY ORAL FLUID MICROFLORA 2015
  • Mikhajlova Elena Sergeevna
  • Samoukina Anna Mikhajlovna
  • Chervinets Vjacheslav Mikhajlovich
  • Chernin Vjacheslav Vasilevich
  • Alekseeva Julija Aleksandrovna
RU2602697C1

RU 2 723 336 C2

Authors

Lindal Torbern

Karlsson Magdalena

Sekelya Monika

Khegge Finn

Dates

2020-06-09Published

2016-03-24Filed